Urine Metabolites in the Diagnosis of Disease | MicrobiomeTrials← Back to trialsNCT06710067
Urine Metabolites in the Diagnosis of Disease
RecruitingOBSERVATIONAL
Trial Details
Start: 2024-10-01Est. Completion: 2025-09
Enrollment target: 1,250 participants Locations- Unio Health Partners (Gastroenterology), Encinitas, California, United States
- Digestive Health Associates, Santa Monica, California, United States
- Westside Gastro Care, Santa Monica, California, United States
- Bass Medical Group (Gastroenterology), Walnut Creek, California, United States
Other microbiome trials you might be interested in
Colorectal Cancer
This is a Phase 1/2 open-label, multicenter study evaluating the safety and efficacy of LYL273 in participants with rela…
Duarte, United StatesEst. completion Jun 2028
Breast CancerGastric CancerEsophageal CancerGastroesophageal CancerColorectal CancerEndometrial CancerNon-small Cell Lung CancerOvarian CancerUrothelial Carcinoma
Salivary Gland Cancer
Pancreatic Cancer
HER-2 Protein Overexpression
The purpose of this study is to evaluate the efficacy and safety of zanidatamab for the treatment of participants with p…
Prescott, United StatesEst. completion Dec 31, 2026
Colorectal Cancer
The purpose of this study is to study the impact of Western lifestyle, including moderate alcohol consumption and delaye…
Chicago, United StatesEst. completion May 31, 2023